Advances in Non-Coding RNAs as Prognostic Biomarkers, Therapeutic Targets, and Regulatory Mechanisms in Cancer
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Biopharmaceuticals".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 800
Special Issue Editors
Interests: non-coding RNAs in cancer; long non-coding RNAs in cancer; prognostic biomarkers in cancer; treatment targets in cancer; molecular mechanisms of long non-coding RNAs in cancer; cancer stem cell phenotype
Special Issue Information
Dear Colleagues,
It is a great pleasure to welcome you to this Special Issue of Pharmaceuticals, titled "Advances in Non-Coding RNAs as Prognostic Biomarkers, Therapeutic Targets, and Regulatory Mechanisms in Cancer". This collection aims to highlight recent progress and emerging concepts in the rapidly expanding field of non-coding RNAs (ncRNAs), with a particular focus on their roles in cancer biology and their potential clinical applications.
In recent years, the scientific community has uncovered the vast complexity and functional significance of ncRNAs, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs). These molecules have been shown to influence critical processes such as tumor initiation, progression, metastasis, therapy resistance, and immune regulation. As a result, ncRNAs are gaining increasing attention as both biomarkers for early diagnosis and prognosis, and as promising therapeutic targets.
This Special Issue welcomes original research articles and reviews addressing the multifaceted roles of ncRNAs in cancer. Topics of interest include molecular mechanisms of action, functional characterization, clinical correlations, biomarker discovery, and ncRNA-based therapeutic strategies.
We hope this Special Issue will contribute to a better understanding of how ncRNAs participate in cancer behavior and how they can be harnessed in precision medicine. We look forward to receiving your contributions and to showcasing the latest advances in this dynamic and promising area of cancer research.
Dr. Pablo Pérez-Moreno
Dr. Juan Pablo Muñoz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-coding RNAs
- non-coding RNAs as prognostic biomarkers in cancer
- non-coding RNAs as treatment targets in cancer
- non-coding RNAs as diagnostic targets in cancer
- molecular mechanisms on non-coding RNAs in cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
